During the past decade, Anhui Cancer Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anhui Cancer Hospital" #1 sponsor was "Beijing InnoCare Pharma Tech Co., Ltd." with 3 trials, followed by "RemeGen Co., Ltd." with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Bai-Rong Xia" with 1 trials sponsored and "CSPC ZhongQi Pharmaceutical Technology Co., Ltd." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anhui Cancer Hospital" #1 collaborator was "Anhui Jimin Cancer Hospital" with 1 trials as a collaborator, "Anhui Provincial Cancer Hospital" with 1 trials as a collaborator, "CSPC ZhongQi Pharmaceutical Technology Co., Ltd." with 1 trials as a collaborator and "Simcere Pharmaceutical Co., Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Anhui Cancer Hospital" are "Gastric Cancer" (2 trials), "Ablation" (1 trials), "Advanced Hepatocellular Carcinoma (HCC)" (1 trials), "Advanced Solid Tumor" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Anhui Cancer Hospital" in a lesser frequency.

Most popular intervention types in "Anhui Cancer Hospital" are "Drug" (16 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "RC48-ADC" (3 trials), "Capecitabine" (2 trials), "ICP-022" (2 trials), "Paclitaxel injection" (2 trials) and "Apatinib Mesylate Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anhui Cancer Hospital" are 17 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Anhui Cancer Hospital". 1 are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Anhui Cancer Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Anhui Cancer Hospital, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".